Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 946 AL 960

Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project

Wang H, Fan Z, Shi C, Xiong L, Zhang H, Li T, Sun Y, Guo Q, Tian Y, Qu Q, Zhang N, Cheng Z, Wu L, Wu D, Han Z, Tian J, Xie H, Tan S, Gao J, Luo B, Pan X, Peng G, Qin B, Tang Y, Wang K, Wang T, Zhang J, Zhao Q, Gauthier S, Yu X.

J Glob Health. 2019 Dec;9(2):020320. doi: 10.7189/jogh.09.020320.

Alzheimer's Disease Classification Based on Multi-feature Fusion

Madusanka N, Choi HK, So JH, Choi BK.

Curr Med Imaging Rev. 2019;15(2):161-169. doi: 10.2174/1573405614666181012102626.

Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults

Racine AM, Merluzzi AP, Adluru N, Norton D, Koscik RL, Clark LR, Berman SE, Nicholas CR, Asthana S, Alexander AL, Blennow K, Zetterberg H, Kim WH, Singh V, Carlsson CM, Bendlin BB, Johnson SC.

Brain Imaging Behav. 2019 Feb;13(1):41-52. doi: 10.1007/s11682-017-9732-9.

Analysis of long noncoding RNAs highlights region-specific altered expression patterns and diagnostic roles in Alzheimer's disease

Zhou M, Zhao H, Wang X, Sun J, Su J.

Brief Bioinform. 2019 Mar 25;20(2):598-608. doi: 10.1093/bib/bby021.

Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease

Karim R, Koc M, Rettberg JR, Hodis HN, Henderson VW, St John JA, Allayee H, Brinton RD, Mack WJ.

Menopause. 2019 Jan;26(1):7-15. doi: 10.1097/GME.0000000000001160.

Current State of Saliva Biomarkers for Aging and Alzheimer's Disease

François M, Bull CF, Fenech MF, Leifert WR.

Curr Alzheimer Res. 2019;16(1):56-66. doi: 10.2174/1567205015666181022094924.

Olfactory and other sensory impairments in Alzheimer disease

Murphy C.

Nat Rev Neurol. 2019 Jan;15(1):11-24. doi: 10.1038/s41582-018-0097-5.

Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study

Pérez-Grijalba V, Romero J, Pesini P, Sarasa L, Monleón I, San-José I, Arbizu J, Martínez-Lage P, Munuera J, Ruiz A, Tárraga L, Boada M, Sarasa M.

J Prev Alzheimers Dis. 2019;6(1):34-41. doi: 10.14283/jpad.2018.41.

Key Peptides and Proteins in Alzheimer's Disease

Penke B, Bogár F, Paragi G, Gera J, Fülöp L.

Curr Protein Pept Sci. 2019;20(6):577-599. doi: 10.2174/1389203720666190103123434.

Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease

Pulliam L, Sun B, Mustapic M, Chawla S, Kapogiannis D.

J Neurovirol. 2019 Oct;25(5):702-709. doi: 10.1007/s13365-018-0695-4. Epub 2019 Jan 4.

Astrocyte Biomarkers in Alzheimer's Disease

Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER.

Trends Mol Med. 2019 Feb;25(2):77-95. doi: 10.1016/j.molmed.2018.11.006. Epub 2019 Jan 2.

Exploring the relationship between physical activity, beta-amyloid and tau: A narrative review

Brown BM, Peiffer J, Rainey-Smith SR.

Ageing Res Rev. 2019 Mar;50:9-18. doi: 10.1016/j.arr.2019.01.003. Epub 2019 Jan 4.

Association Between Brain β-Amyloid and Frailty in Older Adults

Maltais M, De Souto Barreto P, Hooper C, Payoux P, Rolland Y, Vellas B; MAPT/DSA Study Group.

J Gerontol A Biol Sci Med Sci. 2019 Oct 4;74(11):1747-1752. doi: 10.1093/gerona/glz009.

Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies

Shen XN, Niu LD, Wang YJ, Cao XP, Liu Q, Tan L, Zhang C, Yu JT.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):590-598. doi: 10.1136/jnnp-2018-319148. Epub 2019 Jan 10.

Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis

Ng TKS, Ho CSH, Tam WWS, Kua EH, Ho RC.

Int J Mol Sci. 2019 Jan 10;20(2):257. doi: 10.3390/ijms20020257.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias